These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Questions pertaining to the etiology and pathophysiology of polymyositis/dermatomyositis. Sontheimer RD; Ziff M Clin Dermatol; 1988; 6(2):105-19. PubMed ID: 3293738 [No Abstract] [Full Text] [Related]
7. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis]. Cherin P Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990 [TBL] [Abstract][Full Text] [Related]
8. An overview of polymyositis and dermatomyositis. Findlay AR; Goyal NA; Mozaffar T Muscle Nerve; 2015 May; 51(5):638-56. PubMed ID: 25641317 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Lundberg I; Kratz AK; Alexanderson H; Patarroyo M Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873 [TBL] [Abstract][Full Text] [Related]
10. [Polymyositis and dermatomyositis (a report of 83 cases)]. Chen DR Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Apr; 21(2):107-9, 128. PubMed ID: 3208605 [No Abstract] [Full Text] [Related]